Glaukos GKOS
NYSE GKOS
$183.60 -5.95 (-3.14%)
At close: Aug 20, 2026 · 2:21 PM UTC

Glaukos (GKOS) Operating Margin Growth (1y) (2015 - 2026)

Glaukos (GKOS) Operating Margin Growth (1y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Abbott Laboratories 199.49 Bn 193.88 Bn 7.27 Bn -497.00
2 Stryker 127.80 Bn 124.32 Bn 4.50 Bn 670.00
3 Medtronic 118.98 Bn 109.76 Bn 6.41 Bn 301.00
4 Boston Scientific 73.58 Bn 73.04 Bn 3.85 Bn 546.00
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn 264.00
6 Dexcom 34.34 Bn 32.39 Bn 830.00 Mn 595.00
7 GE HealthCare Technologies 33.76 Bn 31.66 Bn 2.18 Bn 89.00
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn -247.00
9 Steris 23.07 Bn 22.59 Bn 684.20 Mn 146.00
10 Glaukos 10.79 Bn 10.68 Bn 151.59 Mn 898.00

Historic Data

Download Data
DateValue
Jun 30, 2026 898.00
Mar 31, 2026 620.00
Dec 31, 2025 -7,056.00
Sep 30, 2025 1,325.00
Jun 30, 2025 1,304.00
Mar 31, 2025 2,624.00
Dec 31, 2024 1,972.00
Sep 30, 2024 1,038.00
Jun 30, 2024 484.00
Mar 31, 2024 -98.00
Dec 31, 2023 47.00
Sep 30, 2023 -557.00
Jun 30, 2023 1,441.00
Mar 31, 2023 -5,911.00
Dec 31, 2022 -2,296.00
Sep 30, 2022 -4,508.00
Jun 30, 2022 -3,236.00
Mar 31, 2022 3,184.00
Dec 31, 2021 -884.00
Sep 30, 2021 3,381.00